Thursday night I watched a really informative Webinar with Dr Ashish Jha who is just stepping down as the Director of Harvard Global Health Institute.  He gave an overview of where we are at in the Covid19 pandemic, where we’re likely to be going, and tips on how best to navigate the stormy waters.

It was immensely watchable, very informative, and he had timely thoughts, specifically about schools and Covid19.  Thanks go to Jake Auchincloss for organizing the Webinar.

Watch Thursday night’s teleconference here:
 
Highlights from Dr. Jha’s analysis:

Global:

  • Hotspots are U.S., Brazil & India. Outbreaks in other countries are small compared to those three.
  • Globally, we’re in reasonably good shape. 
  • Countries have used a combination of four tools to effectively respond: masks, testing, contact-tracing, and lockdowns. Many countries have applied the four in different proportions to achieve low transmission.
  • Part of the reason why Sweden has done reasonably well is due to built-in social distancing — half of their households are single individuals living alone. But a comparison to Denmark shows that the Swedish initial response was not wise.
United States:
  • August has been better than July.
  • Most people in most countries are “gobsmacked” at the U.S. COVID-19 response.
  • America shouldn’t be seen as a single nation — but a patchwork of state responses. States like Massachusetts look like Western Europe in their response, others in the South look like Brazil.
  • Has there been an increase in competence from the Trump administration over the summer? No.
  • In June and July, a lot more young people have been infected.
  • Mortality in hospitals, for the same person, has declined 40-60% — meaning: if someone is infected today, they have about half the risk of dying as they would have had four months ago. This is due to improvements in both clinical practices and treatments.
  • In most places, there is little worry about hospital surges. Dr. Jha thinks we’ll get through the rest of this pandemic without more ventilator shortages in the U.S.
  • Everywhere that cases have surged, disproportionate impact on communities of color has followed. The numbers are staggering, and there are many explanations: who can work remotely, where we’ve set up testing sites, transmission in multigenerational households, pre-existing co-morbidities, those we deem essential workers, and the quality of care available in lower income neighborhoods.
Massachusetts:
  • Testing in Massachusetts is in pretty good shape. It’s one of the states with the highest level of testing.
  • In early August, Governor Baker listened to the data on an uptick in cases and reined in the re-opening. Dr. Jha wishes he had reined in a bit more, but he credits him with stabilizing the uptick.
What does Dr. Jha do?
  • Public transportation? The latest data suggests that perhaps we were overstating how big of a problem public transportation is. Dr. Jha would get on a T (not during rush hour) with a mask — and preferably with the windows open.
  • Restaurants? No indoor dining, but yes outdoor.
  • Outdoors with others: limited numbers, keeping distance, and with masks if closer than six feet.
Schools:
  • The single biggest determinant of whether we can open schools safely is the level of community transmission. Massachusetts is pretty low, at about 2%.
  • Once community transmission is at a pretty good level – experts differ at whether that’s 3% or 5% – schools could reopen. Need universal masking, better ventilation (best is opening the windows), and testing.
  • Choosing to be remote-only is not a cost-free choice, Dr. Jha says. The achievement gap has gotten worse, and it is low-income and minority kids who are hurt most. Childcare burdens fall disproportionately on women, and there exist large, longstanding labor market effects on women and their careers. It’s not perfect and ideal to get kids back to school in-person. But keeping kids at home is costly.
  • Younger kids transmit less than older kids do — and kids who are really young (K–5) transmit a lot less.
  • You can’t run schools without teachers and staff, and if you can’t keep teachers safe, you can’t reopen a school, Dr. Jha says. We’ve got to take care of our teachers, and must fully accommodate remote teaching for those who are high-risk.
Colleges:
  • There are public-health-driven approaches, and then there are reckless approaches to re-opening college. UNC was reckless.
  • If your policy is contingent on 18- to 22-year-olds behaving well, every single day, for the next year, that’s a bad policy, says Dr. Jha. Need to create a bubble with rigorous surveillance testing.
Vaccine & Path Forward:
  • If this weren’t a presidential election year, Dr. Jha expects that we’d get results from vaccine trials in November/December, FDA emergency use authorization in December, start vaccinating healthcare workers in December, and a large part of country would get vaccinated Feb/March/April — things would look much better by next June. Jha expects that, two weeks before the election, the FDA will issue an emergency use authorization based on incomplete data and we’re likely to see a politicization of the issue.
  • The FDA has become politicized by the Trump administration. Jha is very worried about what is going to happen in the weeks leading up to the election.
  • By the end of 2020, we will have 2-4 vaccines that will look pretty safe and effective. Based on what Dr. Jha expects under a normal scientific process, sometime in late 2020 or early 2021, many of us would get a vaccine (depending on strategy). 
  • A vaccine will dramatically slow transmission, but it won’t bring us back to normal immediately.
What should Biden do in his first six months?
  • Be clearer about the path ahead. Current administration keeps promising miracle cures and short-term solutions. People have to adjust behavior to match reality.
  • If tomorrow morning we wanted to bring this pandemic to a close, we could within the next six weeks. We need to turn to cheap, ubiquitous testing. The technology exists, is cheap, and works, but it’s not being used.
  • How do we get through this? Our three best tools: Testing, masking, and avoiding large indoor gatherings.